[Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure]. 1990

T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
First Department of Internal Medicine, Hiroshima University School of Medicine.

To elucidate the hemodynamic responses to sublingual nifedipine administration during exercise and recovery in congestive heart failure, 16 patients with dilated cardiomyopathy (DCM) and 11 controls were studied using supine bicycle exercise testing. The cardiac index (CI) was measured at rest, at peak exercise and successively during recovery by the thermodilution method. The heart rate (HR), mean blood pressure (mBP) and mean pulmonary arterial pressure (mPAP) were measured every minute. The same exercise load and hemodynamic measurements were repeated about 30 min after the sublingual administration of 10 mg nifedipine. The recovery slope in each parameter was analyzed using an exponential function (Cp = C1ekt). The regression coefficient in each parameter was defined as a CI slope, an HR slope, an mBP slope and an mPAP slope. Before the administration of nifedipine, CI at peak exercise was lower, mPAP during recovery was persistently higher and the CI slope was more blunt in DCM patients, compared with those of the controls. With the administration of nifedipine, CI and HR increased or tended to increase, mBP decreased throughout the exercise and recovery, and mPAP decreased at rest, at peak exercise and one min after exercise in the controls. In DCM patients, however, the CI increased, mBP and mPAP decreased nearly throughout the exercise and recovery, while HR increased throughout the exercise and recovery, except at peak exercise. The CI, HR and mPAP slopes were blunted in the controls; whereas, each slope showed no change in DCM patients. These results suggest that sublingual nifedipine administration can reduce both the preload and afterload, and increase CI throughout exercise and recovery without significant alteration in the recovery course.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D012146 Rest Freedom from activity. Rests
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure

Related Publications

T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
December 1979, Japanese circulation journal,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
January 1987, Kokyu to junkan. Respiration & circulation,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
January 1987, Pharmacotherapy,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
May 1984, The American journal of cardiology,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
May 1993, Japanese circulation journal,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
September 1980, The American journal of cardiology,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
June 1999, The American journal of cardiology,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
January 1984, Indian heart journal,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
November 1985, American heart journal,
T Yamagata, and M Okamoto, and M Hashimoto, and H Amioka, and H Nakagawa, and N Morichika, and T Kawagoe, and Y Tsuchioka, and H Matsuura, and G Kajiyama
May 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!